Gene · 8030
Papers1,913
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 1,913
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Combatting acquired resistance to osimertinib in EGFR-mutant lung cancer. | Ther Adv Med Oncol | 2022 | 36544540 | PubTator, text mining | PubMed |
| Identification and characterization of novel elastin gene mutations in eleven families with supravalvular aortic stenosis. | Front Genet | 2022 | 36518217 | PubTator, text mining | PubMed |
| Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology. | Int J Mol Sci | 2022 | 36499450 | PubTator, text mining | PubMed |
| Non-Small Cell Lung Cancer Targeted Therapy: Drugs and Mechanisms of Drug Resistance. | Int J Mol Sci | 2022 | 36499382 | PubTator, text mining | PubMed |
| Therapeutic strategies for EGFR-mutated non-small cell lung cancer patients with osimertinib resistance. | J Hematol Oncol | 2022 | 36482474 | PubTator, text mining | PubMed |
| Partial response to pralsetinib in an advanced pulmonary sarcomatoid carcinoma patient harboring a KIF5B-RET rearrangement: a case report. | World J Surg Oncol | 2022 | 36471407 | PubTator, text mining | PubMed |
| Concordance Between Recommendations From Multidisciplinary Molecular Tumor Boards and Central Consensus for Cancer Treatment in Japan. | JAMA Netw Open | 2022 | 36469316 | PubTator, text mining | PubMed |
| Functional properties of circular RNAs and research progress in gastric cancer. | Front Oncol | 2022 | 36465346 | PubTator, text mining | PubMed |
| T cells of colorectal cancer patients' stimulated by neoantigenic and cryptic peptides better recognize autologous tumor cells. | J Immunother Cancer | 2022 | 36460334 | PubTator, text mining | PubMed |
Rapamycin and inulin for third-dose vaccine response stimulation (RIVASTIM): Inulin - study protocol for a pilot, multicentre, randomised, double-blinded, controlled trial of dietary inulin to improve SARS-CoV-2 vaccine response in kidney transplant recipients. | BMJ Open | 2022 | 36456021 | PubTator, text mining | PubMed |
| Durable response to low-dose pralsetinib in a renal insufficient patient with NSCLC harboring concurrent CCDC6-RET, LINCO1264-RET, and SEMA5A-RET fusions: A case report. | Medicine (Baltimore) | 2022 | 36451418 | PubTator, text mining | PubMed |
| An investigation of codon usage pattern analysis in pancreatitis associated genes. | BMC Genom Data | 2022 | 36434531 | PubTator, text mining | PubMed |
| Determination of skeletal muscle mass by aspartate aminotransferase / alanine aminotransferase ratio, insulin and FSH in Chinese women with sarcopenia. | BMC Geriatr | 2022 | 36419004 | PubTator, text mining | PubMed |
| dTMP imbalance through thymidylate 5'-phosphohydrolase activity induces apoptosis in triple-negative breast cancers. | Sci Rep | 2022 | 36414668 | PubTator, text mining | PubMed |
| Towards a single-assay approach: a combined DNA/RNA sequencing panel eliminates diagnostic redundancy and detects clinically-relevant fusions in neuropathology. | Acta Neuropathol Commun | 2022 | 36397144 | PubTator, text mining | PubMed |
| Efficacy of osimertinib in a metastatic lung adenocarcinoma patient harboring somatic EGFR delL747_S752 and germline BIM deletion polymorphism: a case report and literature review. | Transl Cancer Res | 2022 | 36388025 | PubTator, text mining | PubMed |
| DNA methylation predicts the outcome of COVID-19 patients with acute respiratory distress syndrome. | J Transl Med | 2022 | 36371196 | PubTator, text mining | PubMed |
| Landscape of potentially targetable receptor tyrosine kinase fusions in diverse cancers by DNA-based profiling. | NPJ Precis Oncol | 2022 | 36369474 | PubTator, text mining | PubMed |
| RET Proto-Oncogene-Not Such an Obvious Starting Point in Cancer Therapy. | Cancers (Basel) | 2022 | 36358717 | PubTator, text mining | PubMed |
| Exosome-encapsulated ncRNAs: Emerging yin and yang of tumor hallmarks. | Front Genet | 2022 | 36338993 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8030/papers?page=19